行情

ARAY

ARAY

精确射线公司
NASDAQ

实时行情|Nasdaq Last Sale

3.130
+0.100
+3.30%
盘后: 3.004 -0.127 -4.04% 16:07 09/16 EDT
开盘
3.020
昨收
3.030
最高
3.130
最低
3.000
成交量
66.22万
成交额
--
52周最高
5.40
52周最低
2.350
市值
2.78亿
市盈率(TTM)
-16.5608
分时
5日
1月
3月
1年
5年

分析师评级

6位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ARAY 新闻

  • China Announces Tariff Exclusion for Medical Linear Accelerators
  • PR Newswire.10小时前
  • Why Is Accuray (ARAY) Down 1% Since Last Earnings Report?
  • Zacks.2天前
  • Accuray Appoints Healthcare Veteran James M. Hindman to Board of Directors
  • PR Newswire.3天前
  • Geisinger Medical Center is First in Pennsylvania to Treat Cancer Patients with Accuray Radixact® System
  • PR Newswire.6天前

更多

所属板块

先进医疗设备和技术
-0.24%
医疗设备和用品
-0.36%

热门股票

名称
价格
涨跌幅

ARAY 简况

Accuray Incorporated is a radiation oncology company. The Company develops, manufactures and markets medical devices used in radiation therapy for the treatment of cancer patients. Its products include the CyberKnife Systems, the TomoTherapy Systems, and the Radixact Delivery Treatment Platform. Its technologies, the CyberKnife and TomoTherapy Systems, are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT) and adaptive radiation therapy. The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.
展开

Webull提供Accuray Incorporated的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。